CRISPR/Cas9 screening: unraveling cancer immunotherapy's 'Rosetta Stone'

Area of Science:

• Biomedical research
• Genomics
• Immunology

Background:

• CRISPR-based technology offers unbiased functional genomic screening.
• Cancer immunotherapy has revolutionized cancer treatment.
• Identifying new targets is crucial for improving immunotherapy efficacy.

Purpose of the Study:

• To review advances in CRISPR/Cas9 screening for cancer immunotherapy.
• To outline immunotherapeutic targets identified through CRISPR screening.
• To classify targets based on cancer type.

Main Methods:

• Utilizing CRISPR/CRISPR-associated protein 9 (Cas9) for genetic perturbation screening.
• Analyzing screening data to identify key genes, biomarkers, and pathways.
• Classifying identified targets by cancer type.

Main Results:

• CRISPR screening has identified numerous genes and signaling pathways regulating cancer immunoreactivity.
• Effective immunotherapeutic targets have been discovered using this technology.
• The review categorizes these targets based on specific cancer types.

Conclusions:

• CRISPR/Cas9 screening is a powerful tool for advancing cancer immunotherapy.
• This technology facilitates the discovery of novel therapeutic targets.
• The findings aid in developing more effective and personalized cancer immunotherapies.